Pathology AI
Self-learning pathology AI for toxicology and clinical trial teams.
TileBio Precedent is a preclinical toxicology suite. It detects abnormal tissue, searches by morphology and measures how dose changes morphology. TileBio Motif is for exploratory biomarker discovery in clinical trial slides. Both run on our patented tissue language model, which learns from unlabelled slides.
- Setup
- No labelsYour slides are indexed as they stand
- Method
- PatentedAnd published in Nature Communications
- Whole-slide images
- 2M+Available for model training and validation
- Deployment
- On siteOn your own hardware in Docker, or hosted in the TileBio cloud
Products
For toxicology, clinical trials and bespoke research
Preclinical toxicology · non-GLP
Precedent is our preclinical toxicology suite, for non-GLP use. It does three things.
- Detects abnormal tissue on every slide in a study
- Searches your archive by morphology to find prior cases
- Measures how dose changes morphology across dose groups
Exploratory biomarker discovery
Motif is for exploratory biomarker discovery. It finds the tissue patterns linked to response in clinical trial slides.
- Ranks tissue patterns by their link to response
- Shows example tiles for each pattern
- Reports at cohort level, for research use
Bespoke studies
Runs bespoke computational pathology studies on your slides.
Explore
Technology
A model that learns tissue without labels
Our tissue language model learns from slides that nobody has annotated. It groups tissue into recurring patterns, then reads each slide as an arrangement of those patterns. A pathologist can open any pattern and see the tiles in it.
Partners
Data partnerships with the NHS
TileBio has a data partnership with NHS Greater Glasgow & Clyde and the NHS West of Scotland Innovation Hub. The method is patented and published in Nature Communications.
- NHS Greater Glasgow & Clyde
- NHS West of Scotland Innovation Hub
TileBio has agreed exploratory collaborative studies with Terrain Life Science, and is in discussions with pharmaceutical companies on toxicology and discovery pilots.
Run it on your own slides
Tell us about your study or cohort and the question you want answered.


